Silco Pharmaceuticals Limited (DSE: SILCOPHL)

Silco Pharmaceuticals Revenue

Silco Pharmaceuticals had revenue of 114.69M BDT in the quarter ending September 30, 2024, with 9.41% growth. In the fiscal year ending June 30, 2023, Silco Pharmaceuticals had annual revenue of 464.70M, down -16.94%.

• Revenue: 464.70M
• Revenue Growth: -16.94%
• P/S Ratio: n/a
• Revenue / Employee: n/a
• Employees: 311
• Market Cap: 1.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	464.70M	-94.77M	-16.94%
Jun 30, 2022	559.47M	-41.59M	-6.92%
Jun 30, 2021	601.06M	-132.59M	-18.07%
Jun 30, 2020	733.65M	-185.39M	-20.17%
Jun 30, 2019	919.04M	1.27M	0.14%